Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasminogen activator inhibitor-1 polymorphism is associated with progressive renal dysfunction after acute rejection in renal transplant recipients.

Transplantation - 27 Dec 2002

Chow Kai Ming, Szeto Cheuk Chun, Szeto Carol Yi-Ki, Poon Peter, Lai Fernand Mac-Moune, Li Philip Kam-Tao

Abstract excerpt

BACKGROUND: Plasma level of plasminogen activator inhibitor (PAI)-1 is genetically determined by a polymorphism in the promoter region, involving two alleles, 4G and 5G. Plasma PAI-1 concentrations are higher in subjects homozygous for the 4G allele than other genotypes (5G/5G and 4G/5G). Such ge...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Disease
Share to Follow-Up Studies
Share to Graft Rejection

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kidney

Share to Kidney Transplantation

Share to Plasminogen Activator Inhibitor 1

Share to Risk Factors

Share to Survival Analysis

Source

Identifiers

PMID: 12499900
DOI: 10.1097/00007890-200212270-00026

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-12499900-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasminogen activator inhibitor-1 polymorphism is associated with progressive renal dysfunction after acute rejection in renal transplant recipients.PMID 12499900Read ↗

PAI-1 donor polymorphism influences long-term kidney graft survival.Semantic proximity Read ↗

Chronic graft dysfunction in renal transplant patients: potential role of plasminogen activator inhibitor type 1.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 5G/5G genotype is a protecting factor preventing posttransplant diabetes mellitus.Semantic proximity Read ↗

Impact of plasminogen activator inhibitor-1 gene polymorphisms on primary membranous nephropathy.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 gene polymorphism 4G/4G genotype and lupus nephritis in Chinese patients.Semantic proximity Read ↗

Angiotensinogen and plasminogen activator inhibitor-1 gene polymorphism in relation to chronic allograft dysfunction.Semantic proximity Read ↗

[Relationship between PAI-1 gene 4G/5G polymorphism and clinical profile of IgA nephropathy].Semantic proximity Read ↗

Angiotensinogen, angiotensine converting enzyme and plasminogen activator inhibitor-1 gene polymorphism in chronic allograft dysfunction.Semantic proximity Read ↗

The 4G/4G genotype of the PAI-1 (serpine-1) 4G/5G polymorphism is associated with decreased lung allograft utilization.Semantic proximity Read ↗

4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective study.Semantic proximity Read ↗

Genetic interactions between the donor and the recipient for susceptibility to acute rejection in kidney transplantation: polymorphisms of CCR5.Semantic proximity Read ↗

Outcome of kidney transplantation in patients with inherited thrombophilia: data of a prospective study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.